GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Respiratorius AB (XSAT:RESP) » Definitions » Float Percentage Of Total Shares Outstanding

Respiratorius AB (XSAT:RESP) Float Percentage Of Total Shares Outstanding : 0.00% (As of Apr. 13, 2025)


View and export this data going back to 2012. Start your Free Trial

What is Respiratorius AB Float Percentage Of Total Shares Outstanding?

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Respiratorius AB's float shares is 0.00 Mil. Respiratorius AB's total shares outstanding is 5.10 Mil. Respiratorius AB's float percentage of total shares outstanding is 0.00%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Respiratorius AB's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Respiratorius AB's Institutional Ownership is 0.00%.

Respiratorius AB Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Respiratorius AB's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=0.00/5.10
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Respiratorius AB Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Respiratorius AB (XSAT:RESP) » Definitions » Float Percentage Of Total Shares Outstanding
Comparable Companies
XSAT:DBP B OSTO:CMOTEC B OSTO:STABL OSTO:NANECH OSTO:FLUI OSTO:COMBI OSTO:LPGO OSTO:MODTX XSAT:PHAL OSTO:LIDDS VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
N/A
Address
Scheelevagen 2, Medicon Village, Lund, SWE, 223 81
Website
https://www.respiratorius.com
Respiratorius AB develops pharmaceutical drugs to treat the common diseases namely Cancer, Chronic Obstructive Pulmonary Disease (COPD), and asthma as well as better methods for diagnosing cardiovascular diseases. The company's drug candidates includes RCD405, VAL001, RESP2000, RESP3000, RESP9000, and RESP1000.

Respiratorius AB Headlines

No Headlines